Jenneen DeFiore is an Executive Director and Therapeutic Area Pillar Head for Neuroscience at PPD, part of Thermo Fisher Scientific. She oversees the development, implementation, and operational delivery of both early and late phase clinical trials. Throughout her career, she has primarily focused on rare and ultra-rare disease programs, contributing to the successful market introduction of several compounds.
As a researcher and caregiver of a child and husband with CMT1A, Jenneen DeFiore brings a unique and valuable perspective to the clinical trial landscape for Charcot-Marie-Tooth disease. Her dual roles provide her with deep insights into the challenges and needs of both patients and the scientific community, informing her approach to past, current, and future clinical trials for CMT.